The Veterinary Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (Therapeutics, Diagnostics), By Animal (Dogs and Cats, Horses, Ruminants, Swine, Poultry, Others).
In 2024, the veterinary market continues to be pivotal in providing comprehensive healthcare services and products for the well-being and management of animals across companion, livestock, and exotic species. Veterinary care encompasses a wide range of services, including preventive medicine, diagnostics, surgery, and therapeutics, aimed at promoting animal health, preventing diseases, and ensuring optimal welfare. With advancements in veterinary medicine, technology, and research, the veterinary market offers innovative solutions to address the diverse needs and challenges of animal healthcare, ranging from routine wellness exams and vaccinations to advanced diagnostic imaging and surgical interventions. Moreover, the market is influenced by trends such as the increasing demand for personalized and specialized veterinary care, the adoption of telemedicine and digital health solutions for remote consultations and monitoring, and the integration of holistic and integrative therapies into veterinary practice. Additionally, ongoing research focuses on advancing veterinary vaccines, pharmaceuticals, and medical devices, improving diagnostic accuracy and precision, and enhancing animal welfare standards and ethical considerations in veterinary medicine, reflecting the continuous commitment to advancing the health and well-being of animals worldwide.
One prominent market trend in the veterinary industry is the rise in pet ownership and the humanization of pets. With increasing urbanization, changing lifestyles, and growing disposable incomes, more people are choosing to keep pets as companions. Furthermore, there is a notable trend toward viewing pets as integral members of the family, leading to increased spending on pet healthcare, nutrition, and wellness products and services. This shift in mindset towards pets as family members drives demand for veterinary services, including preventive care, diagnostics, and treatment options, and influences the evolution of the veterinary industry to cater to the needs and preferences of pet owners.
A significant market driver for the veterinary industry is the continuous advances in veterinary medicine and technology. Technological innovations, such as advanced imaging modalities, minimally invasive surgical techniques, genetic testing, and personalized medicine, are revolutionizing veterinary care, enabling more accurate diagnoses, targeted treatments, and improved patient outcomes. Additionally, advancements in pharmaceuticals, vaccines, and nutraceuticals are expanding the treatment options available to veterinarians and improving the quality of care provided to animals. The ongoing development of new veterinary drugs, diagnostic tools, and treatment modalities drives growth and innovation in the veterinary industry, enhancing the capabilities of veterinary professionals to meet the evolving healthcare needs of animals.
One potential opportunity in the veterinary market lies in the adoption of telemedicine and remote consultation services. Telemedicine enables veterinary professionals to provide remote diagnosis, advice, and treatment recommendations to pet owners, offering convenience, accessibility, and cost-effectiveness. With the increasing use of digital communication platforms and telehealth technologies, there is an opportunity for veterinarians to expand their practice beyond traditional brick-and-mortar clinics and reach clients in remote or underserved areas. Additionally, telemedicine can facilitate follow-up consultations, monitoring of chronic conditions, and behavioral counseling, improving continuity of care and client satisfaction. By embracing telemedicine and offering remote consultation services, veterinary practices can enhance client engagement, expand their client base, and improve access to veterinary care for pet owners, while also increasing efficiency and revenue opportunities for the practice.
In the Veterinary Market, the segment experiencing rapid growth is Diagnostics for Dogs and Cats. As the companion animal population continues to grow, particularly in urban areas, there is a corresponding increase in the demand for advanced diagnostic services to ensure the health and well-being of pets. Diagnostic tests such as blood tests, imaging (e.g., X-rays, ultrasound), and molecular diagnostics play a crucial role in early disease detection, monitoring treatment responses, and guiding veterinary care decisions. Moreover, the humanization of pets and the willingness of pet owners to invest in their pets' healthcare further drive the demand for sophisticated diagnostic services in veterinary practice. With technological advancements leading to the development of portable and point-of-care diagnostic devices, the accessibility and efficiency of diagnostic testing for dogs and cats are improving, contributing to the rapid growth of this segment in the veterinary market.
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossBoehringer Ingelheim GmbH, Elanco Animal Health, Hester Biosciences Ltd, IDEXX Laboratories Inc, Indian Immunologicals Ltd, Merck & Co. Inc, Vetoquinol S.A., Virbac S.A., Zoetis Inc, Zydus Cadila
By Product
Therapeutics
-Vaccines
-Parasiticides
-Anti Infectives
-Medical Feed Additives
-Others
Diagnostics
-Immunodiagnostic Tests
-Molecular Diagnostics
-Diagnostic Imaging
-Clinical Chemistry
-Others
By Animal
Dogs and Cats
Horses
Ruminants
Swine
Poultry
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Boehringer Ingelheim GmbH
Elanco Animal Health
Hester Biosciences Ltd
IDEXX Laboratories Inc
Indian Immunologicals Ltd
Merck & Co. Inc
Vetoquinol S.A.
Virbac S.A.
Zoetis Inc
Zydus Cadila
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Veterinary Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Veterinary Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Veterinary Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Veterinary Market Size Outlook, $ Million, 2021 to 2030
3.2 Veterinary Market Outlook by Type, $ Million, 2021 to 2030
3.3 Veterinary Market Outlook by Product, $ Million, 2021 to 2030
3.4 Veterinary Market Outlook by Application, $ Million, 2021 to 2030
3.5 Veterinary Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Veterinary Industry
4.2 Key Market Trends in Veterinary Industry
4.3 Potential Opportunities in Veterinary Industry
4.4 Key Challenges in Veterinary Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Veterinary Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Veterinary Market Outlook by Segments
7.1 Veterinary Market Outlook by Segments, $ Million, 2021- 2030
By Product
Therapeutics
-Vaccines
-Parasiticides
-Anti Infectives
-Medical Feed Additives
-Others
Diagnostics
-Immunodiagnostic Tests
-Molecular Diagnostics
-Diagnostic Imaging
-Clinical Chemistry
-Others
By Animal
Dogs and Cats
Horses
Ruminants
Swine
Poultry
Others
8 North America Veterinary Market Analysis and Outlook To 2030
8.1 Introduction to North America Veterinary Markets in 2024
8.2 North America Veterinary Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Veterinary Market size Outlook by Segments, 2021-2030
By Product
Therapeutics
-Vaccines
-Parasiticides
-Anti Infectives
-Medical Feed Additives
-Others
Diagnostics
-Immunodiagnostic Tests
-Molecular Diagnostics
-Diagnostic Imaging
-Clinical Chemistry
-Others
By Animal
Dogs and Cats
Horses
Ruminants
Swine
Poultry
Others
9 Europe Veterinary Market Analysis and Outlook To 2030
9.1 Introduction to Europe Veterinary Markets in 2024
9.2 Europe Veterinary Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Veterinary Market Size Outlook by Segments, 2021-2030
By Product
Therapeutics
-Vaccines
-Parasiticides
-Anti Infectives
-Medical Feed Additives
-Others
Diagnostics
-Immunodiagnostic Tests
-Molecular Diagnostics
-Diagnostic Imaging
-Clinical Chemistry
-Others
By Animal
Dogs and Cats
Horses
Ruminants
Swine
Poultry
Others
10 Asia Pacific Veterinary Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Veterinary Markets in 2024
10.2 Asia Pacific Veterinary Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Veterinary Market size Outlook by Segments, 2021-2030
By Product
Therapeutics
-Vaccines
-Parasiticides
-Anti Infectives
-Medical Feed Additives
-Others
Diagnostics
-Immunodiagnostic Tests
-Molecular Diagnostics
-Diagnostic Imaging
-Clinical Chemistry
-Others
By Animal
Dogs and Cats
Horses
Ruminants
Swine
Poultry
Others
11 South America Veterinary Market Analysis and Outlook To 2030
11.1 Introduction to South America Veterinary Markets in 2024
11.2 South America Veterinary Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Veterinary Market size Outlook by Segments, 2021-2030
By Product
Therapeutics
-Vaccines
-Parasiticides
-Anti Infectives
-Medical Feed Additives
-Others
Diagnostics
-Immunodiagnostic Tests
-Molecular Diagnostics
-Diagnostic Imaging
-Clinical Chemistry
-Others
By Animal
Dogs and Cats
Horses
Ruminants
Swine
Poultry
Others
12 Middle East and Africa Veterinary Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Veterinary Markets in 2024
12.2 Middle East and Africa Veterinary Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Veterinary Market size Outlook by Segments, 2021-2030
By Product
Therapeutics
-Vaccines
-Parasiticides
-Anti Infectives
-Medical Feed Additives
-Others
Diagnostics
-Immunodiagnostic Tests
-Molecular Diagnostics
-Diagnostic Imaging
-Clinical Chemistry
-Others
By Animal
Dogs and Cats
Horses
Ruminants
Swine
Poultry
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Boehringer Ingelheim GmbH
Elanco Animal Health
Hester Biosciences Ltd
IDEXX Laboratories Inc
Indian Immunologicals Ltd
Merck & Co. Inc
Vetoquinol S.A.
Virbac S.A.
Zoetis Inc
Zydus Cadila
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
Therapeutics
-Vaccines
-Parasiticides
-Anti Infectives
-Medical Feed Additives
-Others
Diagnostics
-Immunodiagnostic Tests
-Molecular Diagnostics
-Diagnostic Imaging
-Clinical Chemistry
-Others
By Animal
Dogs and Cats
Horses
Ruminants
Swine
Poultry
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Veterinary Market is one of the lucrative growth markets, poised to register a 8.4% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Boehringer Ingelheim GmbH, Elanco Animal Health, Hester Biosciences Ltd, IDEXX Laboratories Inc, Indian Immunologicals Ltd, Merck & Co. Inc, Vetoquinol S.A., Virbac S.A., Zoetis Inc, Zydus Cadila
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume